Is TRXPF or RYLD a better dividend investment in 2026?

TRXPF currently yields 3.27% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: RYLD offers higher current income.

What is the dividend yield difference between TRXPF and RYLD?

TRXPF has a forward dividend yield of 3.27% ($0.80/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 8.87 percentage points.

Home › Compare › TRXPF vs RYLD

TRXPF vs RYLD: Dividend Comparison 2026

TRXPF yields 3.27% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 TRXPF wins by $634.89M in total portfolio value· pulled ahead in Year 3

INVESTMENT

TIME HORIZON10 years

TRXPF

● Live price

3.27%

Share price

$24.57

Annual div

$0.80

5Y div CAGR

100%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$634.94M

Annual income

$599,684,359.43

Full TRXPF calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — TRXPF vs RYLD

📍 TRXPF pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TRXPF	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TRXPF + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TRXPF pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TRXPF

Annual income on $10K today (after 15% tax)

$277.78/yr

After 10yr DRIP, annual income (after tax)

$509,731,705.52/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, TRXPF beats the other by $509,729,506.27/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TRXPF + RYLD for your $10,000?

TRXPF: 50%RYLD: 50%

100% RYLD50/50100% TRXPF

Portfolio after 10yr

$317.49M

Annual income

$299,843,473.38/yr

Blended yield

94.44%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TRXPF buys

RYLD buys

No recent congressional trades found for TRXPF or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTRXPFRYLD

Forward yield	3.27%	12.14% ✓
Annual dividend / share	$0.80	$1.81 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	100% ✓	0%
Portfolio after 10y	$634.94M ✓	$44.5K
Annual income after 10y	$599,684,359.43 ✓	$2,587.35
Total dividends collected	$632.35M ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: TRXPF vs RYLD ($10,000, DRIP)

Year	TRXPF Portfolio	TRXPF Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1	$11,354	$653.59	$11,914	$1,213.65	$560.00 → RYLD
2	$13,535	$1,387.04	$14,099	$1,351.30	$564.00 → RYLD
3← crossover	$17,574	$3,090.80	$16,580	$1,494.55	+$994.00 → TRXPF
4	$26,305	$7,500.82	$19,384	$1,642.61	+$6.9K → TRXPF
5	$49,132	$20,985.78	$22,535	$1,794.70	+$26.6K → TRXPF
6	$125,837	$73,265.77	$26,063	$1,950.00	+$99.8K → TRXPF
7	$485,391	$350,745.93	$29,995	$2,107.69	+$455.4K → TRXPF
8	$3,048,220	$2,528,851.81	$34,361	$2,266.99	+$3.01M → TRXPF
9	$32,945,707	$29,684,110.82	$39,194	$2,427.12	+$32.91M → TRXPF
10	$634,936,266	$599,684,359.43	$44,525	$2,587.35	+$634.89M → TRXPF

TRXPF vs RYLD: Complete Analysis 2026

TRXPF — Stock

Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; allergen immunotherapy tablets comprising CEDARCURE and MITICURE; and CORECTIM, a topical janus kinase (JAK) inhibitor. It markets its products primarily through medical representatives for medical professionals. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.

Full TRXPF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this TRXPF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TRXPF vs SCHD TRXPF vs JEPI TRXPF vs O TRXPF vs KO TRXPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.